Home › Attention Deficit Hyperactivity Disorder › Oregon
Attention Deficit Hyperactivity Disorder clinical trials in Oregon
6 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in Oregon.
Cities in Oregon
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Clinical Research Site, Portland
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated Nov 6, 2026 · NCT07717879Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Clinical Research Site, Portland
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Nov 6, 2026 · NCT07717892A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
- Summit Research Network, Portland
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Nov 6, 2026 · NCT07759154Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Cyn3rgy Research, Gresham
RecruitingPhase 4
48 Months – 69 Months · All sexes · Updated Oct 5, 2026 · NCT04781140Focus Groups in Ethnically and Racially Diverse Families
- Oregon Health & Science University, Portland
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 80 · All sexes · Updated Apr 4, 2025 · NCT05930886Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)
- Oregon Health & Science University, Portland
Recruiting
Ages 6 to 17 · All sexes · Updated Jan 16, 2025 · NCT06133231From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.